AI Analysis AI Analysis of NONOF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add NONOF to Watchlist?
Some Reasons Why To Add NONOF:
  • High gross margin of 81.8%
  • Beat earnings estimates in 3 of the last 4 quarters
  • Strong operating margin of 45.3%
PDF

Stronger technical forecast for Novo Nordisk A/S stock price after Tuesday trading
(Updated on Jun 23, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy candidate since Jun 22, 2026 Gain 1.62%

The Novo Nordisk A/S stock price gained 1.62% on the last trading day (Tuesday, 23rd Jun 2026), rising from $46.09 to $46.84. During the last trading day the stock fluctuated 7.49% from a day low at $44.32 to a day high of $47.64. The price has risen in 7 of the last 10 days and is up by 13.55% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 thousand more shares were traded than the day before. In total, 4 thousand shares were bought and sold for approximately $203.80 thousand.

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 23.94% during the next 3 months and, with a 90% probability hold a price between $53.08 and $62.68 at the end of this 3-month period.

NONOF Signals & Forecast

Mostly positive signals in the chart today. The Novo Nordisk A/S stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $44.62 and $44.33. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Monday, June 08, 2026, and so far it has risen 13.55%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Novo Nordisk A/S has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for Novo Nordisk A/S stock

On the downside, the stock finds support just below today's level from accumulated volume at $38.82 and $35.80. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Novo Nordisk A/S finds support just below today's level at $38.82. If this is broken, then the next support from accumulated volume will be at $35.80 and $35.58.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $3.32 between high and low, or 7.49%. For the last week, the stock has had daily average volatility of 6.36%.

Our recommended stop-loss: $45.06 (-3.80%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (NONOF) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Novo Nordisk A/S to open at $46.27, and during the day (based on 14 day Average True Range), to move between $45.59 and $48.09, which gives a possible trading interval of +/-$2.50 (+/-5.48%) up or down from last closing price. If Novo Nordisk A/S takes out the full calculated possible swing range there will be an estimated 5.48% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $38.82, some $8.02 (17.13%) from the current price of $46.84, our system finds the risk reward attractive.

Is Novo Nordisk A/S stock A Buy?

Novo Nordisk A/S holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 5.159 Strong Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $46.27 ( 1.22%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

NONOF Performance

Trading levels for NONOF

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 49.59 5.87%
R2 48.32 3.16%
R1 47.53 1.49%
Price 46.84
S1 45.00 -3.93%
S2 44.21 -5.60%
S3 42.95 -8.31%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0 -
R2 0 -
R1 0 -
Price 46.84
S1 38.82 -17.13%
S2 35.80 -23.56%
S3 35.58 -24.04%

NONOF Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 04, 2026 Mar 30, 2026 Mar 31, 2026 $1.25 2.57%
2 Mar 27, 2026 Mar 27, 2026 Mar 31, 2026 $1.25 2.81%
3 Aug 06, 2025 Aug 18, 2025 Aug 19, 2025 $0.586 1.07%
4 Aug 15, 2025 Aug 15, 2025 Aug 19, 2025 $0.585 1.15%
5 Feb 05, 2024 Mar 31, 2025 Apr 01, 2025 $1.14 1.69%

FAQ

What is the symbol for Novo Nordisk A/S Stock and on which exchange is it traded?
The symbol for Novo Nordisk A/S is NONOF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Novo Nordisk A/S Stock?
Novo Nordisk A/S holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy Novo Nordisk A/S Stock?
Novo Nordisk A/S Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Novo Nordisk A/S Stock.

What's the current price of Novo Nordisk A/S Stock?
As of the end of day on the Jun 23, 2026, the price of an Novo Nordisk A/S (NONOF) share was $46.84.

What is the 52-week high and low for Novo Nordisk A/S Stock?
The 52-week high for Novo Nordisk A/S Stock is $72.61 and the 52-week low is $34.00.

What is the market capitalization of Novo Nordisk A/S Stock?
As of the Jun 23, 2026, the market capitalization of Novo Nordisk A/S is 208.08B.

When is the next earnings date for Novo Nordisk A/S?
The upcoming earnings date for Novo Nordisk A/S is Aug 05, 2026.
Click to get the best stock tips daily for free!
ABOUT NOVO NORDISK A/S
Novo Nordisk A/S
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the ...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE